Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry

BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor with superior clinical efficacy compared with clopidogrel. However, it is associated with reduced efficacy when combined with a high‐dose aspirin. METHODS AND RESULTS: Patients in the acute coronary treatment and intervention outcomes network (A...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Heart Assoc
Main Authors: Basra, Sukhdeep S., Wang, Tracy Y., Simon, DaJuanicia N., Chiswell, Karen, Virani, Salim S., Alam, Mahboob, Nambi, Vijay, Denktas, Ali E., Deswal, Anita, Bozkurt, Biykem, Ballantyne, Christie M., Peterson, Eric D., Jneid, Hani
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220549/
https://ncbi.nlm.nih.gov/pubmed/29886424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.008125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados